Literature DB >> 2226433

Hormone binding to natural mutants of human serum albumin.

U Kragh-Hansen1, L Minchiotti, S O Brennan, O Sugita.   

Abstract

High-affinity binding of progesterone, testosterone, prostaglandin F2 alpha and L-thyroxine to five genetic variants of human serum albumin with defined point mutations was investigated by equilibrium dialysis (pH 7.4). Endogenous albumin A (Alb A) from each individual and commercial human serum albumin were used as controls in each case. The association constant for binding of progesterone to Alb Canterbury (Lys313----Asn) was 1.5 times that calculated for binding to the corresponding, endogenous Alb A. In contrast, the variants Alb Niigata (Asp269----Gly), Alb Roma (Glu321----Lys), Alb Parklands (Asp365----His) and Alb Verona (Glu570----Lys) all had normal progesterone binding properties. Specificity with respect to the type of mutation was also found for the binding of testosterone and prostaglandin F 2 alpha. Testosterone binding to Alb Roma was only 0.7 of that determined for endogenous Alb A, whereas prostaglandin F 2 alpha binding to Alb Niigata was increased by a factor 2.4. In the case of L-thyroxine normal binding properties were found for all the variants. Steric effects and/or conformational changes of the protein, introduced by the amino acid substitutions, probably account for the altered hormone binding. However, in the case of the increased binding of prostaglandin F2 alpha to Alb Niigata electrostatic effects could also be involved. The experimental findings suggest different high-affinity sites for the four hormones. Progesterone, testosterone and prostaglandin F2 alpha are apparently bound within the middle third (domain II) of the protein molecule. The possible position of the primary L-thyroxine site is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226433     DOI: 10.1111/j.1432-1033.1990.tb19319.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

2.  The mechanism of detergent solubilization of liposomes and protein-containing membranes.

Authors:  U Kragh-Hansen; M le Maire; J V Møller
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

3.  A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia.

Authors:  C E Petersen; A G Scottolini; L R Cody; M Mandel; N Reimer; N V Bhagavan
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

4.  Unraveling the Stability of Plasma Proteins upon Interaction of Synthesized Androstenedione and Its Derivatives-A Biophysical and Computational Approach.

Authors:  Aparna Nerusu; P Srinivasa Reddy; Dhevalapally B Ramachary; Rajagopal Subramanyam
Journal:  ACS Omega       Date:  2017-10-09

5.  Testosterone meets albumin - the molecular mechanism of sex hormone transport by serum albumins.

Authors:  Mateusz P Czub; Barat S Venkataramany; Karolina A Majorek; Katarzyna B Handing; Przemyslaw J Porebski; Sandya R Beeram; Kyungah Suh; Ashley G Woolfork; David S Hage; Ivan G Shabalin; Wladek Minor
Journal:  Chem Sci       Date:  2018-12-17       Impact factor: 9.825

6.  Allosterically Coupled Multisite Binding of Testosterone to Human Serum Albumin.

Authors:  Abhilash Jayaraj; Heidi A Schwanz; Daniel J Spencer; Shalender Bhasin; James A Hamilton; B Jayaram; Anna L Goldman; Meenakshi Krishna; Maya Krishnan; Aashay Shah; Zhendong Jin; Eileen Krenzel; Sashi N Nair; Sid Ramesh; Wen Guo; Gerhard Wagner; Haribabu Arthanari; Liming Peng; Brian Lawney; Ravi Jasuja
Journal:  Endocrinology       Date:  2021-02-01       Impact factor: 4.736

Review 7.  A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.

Authors:  Anna L Goldman; Shalender Bhasin; Frederick C W Wu; Meenakshi Krishna; Alvin M Matsumoto; Ravi Jasuja
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 25.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.